Financial Transactions | Medical and Pharma I

Financing and Investment

Nov 24
4 min

Nyra Medical closes on $20 Million to advance its transcatheter heart valve repair technology

Nyra Medical is a medical device company with the motto "simplifying transcatheter repair of heart valves…one valve at a time"

Nov 23
3 min

scPharmaceuticals Announces Pricing of $50 Million Public Offering

scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that have the potential...

Nov 18
3 min

Fathom, the leader in medical coding automation, closes $46 million financing

Widespread autonomous medical coding is one of the first steps to rebuilding America’s healthcare payments system...

Nov 11
3 min

White Oak Healthcare provides financing for United Dental's acquisitions in four states

UDC’s first wave of practices features a mix of specialty and general practice dentists located in key markets in four states.

Nov 9
7 min

Led by Medtronic, Cloud DX Announces Consortium to Advance Affordable Hospital-Level Care at Home

The remote patient monitoring system project will be led by Medtronic and include expertise and technology from a consortium of partners.

Oct 28
2 min

Biotech Fund launched with $100 Million of Assets to Focus on Better Drugs, Devices and Diagnostics

Its initial investments include Neuralink, Elon Musk’s brain-computer interface start-up, and Kling Biotherapeutics.

Oct 25
3 min

Shadowbox, a healthcare automation solutions innovator, closes “up to” $6 million financing

By powering a browser with security, AI, and user-driven cross-application connections. Shadowbox offers instant integration and automation.

Oct 15
4 min

Integrated Drug Development Solution Company Altasciences Expands Support for Early Drug Development

The company is focused on innovative targeted radiopharmaceuticals for the diagnosis, monitoring, and therapy of cancer.

Oct 8
4 min

RadioMedix raises $40 million to advance its alpha therapy platform for oncology

Targeted alpha therapies are currently considered one of the most advanced technologies available to treat patients with incurable cancers.

Oct 2
4 min

CXL Ophthalmics announces $32 Million investment to advance its treatment for keratoconus

“EpiSmart has the potential to be a game-changer for the treatment for keratoconus.

Sep 3
5 min

Early-stage novel cell therapy company Neukio Biotherapeutics closes a $50 million financing

The transition from traditional small molecules and antibodies to the era of cell therapy is a great leap in drug design and manufacturing

Aug 16
2 min

CareHarmony raises $15 million to fuel the development of its proprietary CareBlocks technology

This capital will help us deliver on our commitment to bring efficient, impactful, and measurable virtual care to every patient.

Aug 13
2 min

Clario invests in new technology to reduce translation times for clinical trials

For nearly 50 years, Clario has been delivering the leading endpoint technology solutions for clinical trials.

Aug 8
2 min

Helius Medical Technologies Prices $18 Million Public Offering

The Company’s commercial product is the Portable Neuromodulation Stimulator (PoNS™).

Aug 5
2 min

Immunis Closes $10 Million to advance its immunomodulatory secretome product for muscle atrophy

Immunis’ FDA Phase 1/2a clinical trial is a study to assess IMM01-STEM in elderly participants with muscle atrophy.

Aug 3
3 min

IDRx raises $122 million to transform cancer treatment with precision combination therapies

IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision therapies.

Jul 28
2 min

PreciPoint raises €10 million to advance the digitization of intraoperable cancer surgery

PreciPoint is an ISO 13485 certified medical device company and one of the top startups in Germany.

Jul 26
2 min

causaLens partners with the Mayo Clinic to further develop non-invasive methods for cancer screening

There is an urgent clinical need for techniques that can reliably detect early-stage colorectal cancers via non-invasive methods.

Jul 23
3 min

Theator raises an additional $24 million for its Surgical Intelligence Platform for operating rooms

Theator is pioneering the Surgical Intelligence revolution, harnessing advanced AI and computer vision technology

Jul 16
3 min

SIFT HEALTHCARE raises $9 million for its AI-based Payments Intelligence Platform for reimbursement

This financing supports the company’s accelerating sales of its denials management and patient payment solutions

Jul 15
3 min

Manifold Bio Raises $40 Million for its next-generation protein engineering platform

Manifold Bio is a fully-integrated biotechnology company pursuing a pipeline of targeting-enhanced protein therapeutics.

Jul 9
4 min

Kernal Biologics Raises $25 Million to Advance its mRNA 2.0 Technology for Oncology

There’s a major unmet need to improve outcomes for cancer patients and Kernal Bio has built a strong rational for the use of its novel mRNA

Jun 29
2 min

Deep Blue Medical Advances closes financing to scale up its T-Line Hernia Mesh to meet demand

Deep Blue Medical Advances is developing novel hernia surgery products to address hernia occurrence and recurrence

Jun 25
4 min

Health Tech Start-up Spry Raises Funds to Advance Practice Management for Physical Rehabilitation

Spry is a purpose built platform for the physical rehabilitation industry.

Jun 22
2 min

Medical device company Artio Medical raises an additional $28 million for vascular and cardiology

Artio Medical is a medical device company committed to developing innovative products for peripheral vascular and cardiovascular diseases.

Jun 17
3 min

NOWATCH raises $8.7 million to advance its wearable device to predict stress through cortisol levels

In partnering with Philips, NOWATCH’s unique ability to help users understand and navigate their cortisol levels is set...

Jun 12
2 min

Degron Therapeutics Raises $22 Million for its Molecular-Glue-Based Targeted Protein Degradation

The company’s pipeline includes a growing number of preclinical compounds for oncology, inflammation, metabolic disease, and rare diseases.

Jun 8
3 min

L7 Informatics Raises $38 Million to Accelerate Innovation in Precision Healthcare

Over the last decade, personalized healthcare has spread beyond oncology and now comprises almost half of all new drugs in development.

Jun 7
2 min

OriCiro Closes on Financing to Advance Cell-Free Cloning technology for Large Circular DNA

OriCiro Genomics’ unique cell-free DNA technology has a tremendous potential for business applications, particularly for healthcare.

May 27
4 min

Parallel Learning closes on $20 million to test, diagnose and empower special needs students

Our mission is to work hand-in-hand with school districts and families to deliver the highest quality developmental services.

May 23
1 min

Today’s climate for cross-border transactions and venture capital financing for medical devices

A MedTalks commentary by Jeffrey Friedland

May 20
4 min

ApiJect raises $111 million to transform the fill, finish and delivery of injectable vaccines

ApiJect is developing a truly innovative technology, that could transform the manufacturing and delivery of life-saving injectable drugs.

May 13
4 min

GE Healthcare agrees to invest up to $50 million in Israeli start-up Pulsenmore

This investment is aimed at accelerating global adoption of Pulsenmore’s homecare ultrasound solutions.

May 8
8 min

Tubulis closes on $63 Million to advance its pipeline of uniquely assembled antibody drug conjugates

Tubulis’ capability of creating antibody-drug conjugates is based on a range of targeting molecules, novel payloads and technology.

Apr 26
2 min

Fathom receives investment to drive innovation and performance of medical coding

Fathom is a medical coding automation platform, an AI solution that fuses the best of deep learning and Natural Language Processing

Apr 25
3 min

Syllable Raises $40 Million to Improve the Patient Experience with Intelligent Voice Solutions

Syllable is an AI-enabled healthcare services company that transforms the way health systems provide access to care.

Apr 23
3 min

With an additional $16 million, 9am.health will advance its care for people living with diabetes

Innovative virtual care provider is now available in 47 states and D.C. directly to consumers, providing personalized treatment plans to...

Apr 16
2 min

Koelis closes $10.8 million financing for image-guided prostate cancer interventions

Koelis is a leader in the market for image-guided prostate cancer interventions including biopsy diagnosis and minimally invasive s

Apr 15
4 min

With new funding, Pictor partners with Mobility Health for a SARS-CoV-2 antibody test

“The PictArray™ SARS-CoV-2 Antibody Test is a high performance, all-in-one, NP/SP COVID-19 antibody test with serological differentiation.

Apr 13
3 min

Surf Bio Wraps up $16 Million Seed Financing to Advance Breakthrough Drug Stabilization Technology

Surf Bio is a preclinical biopharmaceutical company leveraging a novel biotechnology platform to develop enhanced therapeutic solutions,,,

Apr 12
3 min

Daewoong Pharmaceutical and HanAll Biopharma Invest in Turn Biotechnologies for mRNA Medicines

Turn Bio is a pre-clinical-stage biopharmaceutical company focused on cellular repair via epigenetic reprogramming of cells.

Apr 10
3 min

VASC Srl closes on $1.96 millon to launch VELEX for the treatment of Chronic Venous Insufficiency

We are now on the verge of bringing VELEX™ into the market and provide proof of the validity of our EVA (Empty Vein Ablation) procedure.

Apr 9
4 min

Doceree raises $11 Million for a network of physician-only platforms for programmatic messaging

Doceree is transforming the way digital interactions between pharmaceutical brands and prescribers are facilitated.

Apr 7
2 min

ENDOVASCULAR ENGINEERING CLOSES ON $15 MILLION FOR VENOUS THROMBECTOMY SOLUTIONS

"With the close of this funding we will continue the journey from concept to clinical use/"

Mar 26
3 min

Geneos Therapeutics closes on $17 million to advance its personalized cancer immunotherapy platform

Globally, liver cancers are the fourth most common cause of cancer-related death and ranked sixth in terms of annual incidence.

Mar 21
3 min

Triumvia Immunologics completes $100 million round for its T cell therapeutics

“Cell therapies have become an essential modality in the oncology therapeutic arsenal and a priority for many biopharma companies.

Mar 18
2 min

MedTex Ventures raises $46.5 million to invest in early-stage medical devices

MedTex Ventures has partnered with Biotex Inc. to help source, analyze, develop, finance and manage medical device companies.

Mar 13
5 min

HTL Biotechnology makes strategic investment in GelMedix, for ocular and regenerative therapies

GelMEDIX's most advanced program is focused on developing a sustained release corticosteroid subconjunctival implant.

Mar 12
2 min

LumiThera obtains $5.5 million to support its macular degeneration product line

Products are a diagnostic and monitoring system that measures the electrical activity of the retina in response to a light stimulus.

Mar 11
2 min

The oncology biotech startup DeoBioSciences completes crowdfunding campaign

DeoBioSciences is developing DBX-31, a naturally sourced anticancer protein to address a wide range of advanced stage cancer types.